| Date | Title | Description |
| 26.10.2023 | - | 3B FUTURE HEALTH GP S.a.r.l. is delighted to announce that 3B Future Health Fund II hosted its first... |
| 18.04.2023 | - | London, UK, 18 April 2023, -NeoPhore Limited, a small molecule neoantigen immuno-oncology company, t... |
| 14.04.2023 | - | NEWS PROVIDED BY |
| 19.01.2023 | - | Cambridge, UK, 19 January 2023 – NeoPhore Limited, a small molecule neoantigen immuno-oncology compa... |
| 20.12.2022 | - | Funding will support iOnctura’s clinical program for IOA-289, a first-in-class autotaxin inhibitor f... |
| 17.11.2022 | - | PRESS RELEASE
Stockholm, Sweden, November 17, 2022
AnaCardio Receives Regulatory Approval to Start a... |
| 19.10.2022 | - | – Clinical trial applications accepted in France and Belgium for initiation of Phase I clinical tria... |
| 11.10.2022 | - | October 04, 2022 05:00 AM Eastern Daylight Time |
| 22.09.2022 | - | Series A funding round initiated to further fund the clinical development of its “First In Class” sm... |
| 08.09.2022 | - | AnaCardio raises SEK 150 million to advance drug candidate AC01 in heart failure |
| 28.06.2022 | - | Strasbourg, France – Montreal, Canada, June 28, 2022 – Domain Therapeutics, a biopharmaceutical comp... |
| 11.05.2022 | - | WEST LAFAYETTE, Ind., May 11, 2022 /PRNewswire/ — On Target Laboratories, Inc., a privately held bio... |
| 10.05.2022 | - | To accelerate clinical development of its best-in-class and first-in-class immuno-oncology programs |
| 16.03.2022 | Kither Biotech Raises €18.5 Million Series B and Appoints Dr... | Turin, Italy, 16 March 2022 Kither Biotech (Kither or the Company), a biopharmaceutical company deve... |
| 02.03.2022 | Epsilogen Announces Completion of Oversubscribed £30.75 Mill... | Financing led by Novartis Venture Fund and joined by new investors 3B Future Health Fund, British Pa... |
| 21.02.2022 | Labcorp Completes Acquisition of Personal Genome Diagnostics | BURLINGTON, N.C., Feb. 21, 2022 — Labcorp (NYSE: LH), a leading global life sciences company, today ... |
| 27.01.2022 | 3B Future Health promotes Marianne Bjørdal to Partner | 3B Future Health Ventures is pleased to announce the promotion of our colleague Marianne Bjørdal to... |
| 29.11.2021 | FDA Approves New Imaging Drug to Help Identify Ovarian Cance... | The U.S. Food and Drug Administration today approved Cytalux (pafolacianine), an imaging drug intend... |
| 23.11.2021 | FDA approves sirolimus protein-bound particles for malignant... | On November 22, 2021, the Food and Drug Administration approved sirolimus protein-bound particles fo... |
| 23.11.2021 | Aadi Bioscience Announces FDA Approval of its First Product ... | LOS ANGELES, Nov. 23, 2021 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a bioph... |
| 02.11.2021 | OncoResponse Announces Initiation of Phase 1 Trial of OR2805... | SEATTLE, Nov. 2, 2021 /PRNewswire/ — OncoResponse, a clinical-stage biotech company advancing immuno... |
| 26.10.2021 | GenEp Raises $1.45 Million Seed Financing | Financing will support development of first-in-class CNS-selective sodium channel modulators |
| 06.10.2021 | OncoResponse Announces Presentations at the Society for Immu... | SEATTLE, Washington – October 6, 2021 – OncoResponse, a clinical-stage biotech company advancing imm... |
| 26.08.2021 | Aadi Bioscience Announces Closing of Merger with Aerpio Phar... | LOS ANGELES, Aug. 26, 2021 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (“Aadiâ€) (Nasdaq: AADI), a c... |
| 10.08.2021 | Tesis Labs and Personal Genome Diagnostics Announce Collabor... | BALTIMORE & HOUSTON–(BUSINESS WIRE)–Tesis Labs, a leader in targeted genetic sequencing, and Per... |
| 03.08.2021 | Personal Genome Diagnostics Appoints Jamie Platt, Ph.D., as ... | BALTIMORE, Md.–(BUSINESS WIRE)– Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics... |
| 20.07.2021 | iOnctura Announces First Subject Dosed in Healthy Volunteer ... | • Safety, pharmacokinetic and pharmacodynamic readouts expected Q4 2021 |
| 07.07.2021 | ONCORESPONSE APPOINTS SEAN McCARTHY TO BOARD OF DIRECTORS | SEATTLE, Washington – July 7, 2021 – OncoResponse, a biotechnology company harnessing the
power ... |
| 15.06.2021 | UTILITY Therapeutics Preparing NDA Submission | LONDON, ENGLAND / ACCESSWIRE / June 15, 2021 /Â UTILITY therapeutics Ltd., a biotechnology company f... |
| 15.06.2021 | Personal Genome Diagnostics Enters Collaborative Partnership... | BALTIMORE, MD, June 15, 2021 – Personal Genome Diagnostics Inc. (PGDx), a leader in cancer
genomic... |
| 10.06.2021 | Gain Therapeutics Announces Issuance of Two New PCT Patents ... | Activity of GBA and GALC Enzymes Play Key Roles in the Neurodegenerative Diseases and Lysosomal Stor... |
| 19.05.2021 | Fore Biotherapeutics Strengthens Leadership Team with Execut... | Company appoints biotech industry experts Stacie Peacock Shepherd, M.D., Ph.D., as Chief Medical Off... |
| 17.05.2021 | Aerpio Pharmaceuticals and Aadi Bioscience Enter into a Defi... | CINCINNATI and PACIFIC PALISADES, Calif., May 17, 2021 (GLOBE NEWSWIRE) — Aerpio Pharmaceuticals, In... |
| 11.05.2021 | UTILITY Therapeutics Announces Scientific Advisory Board | LONDON, UK / ACCESSWIRE / May 11, 2021 /Â UTILITY therapeutics Ltd., a biotechnology company focused... |
| 11.05.2021 | OncoResponse Appoints Chris Russell as Chief Financial Offic... | SEATTLE, May 11, 2021 (GLOBE NEWSWIRE) — OncoResponse, a biotechnology company harnessing the power ... |
| 10.05.2021 | Fore Biotherapeutics Opens U.S. Headquarters in Philadelphia... | Company to begin actively recruiting in Philadelphia, enabling creation of hundreds of new biotech j... |
| 13.04.2021 | Start-up GreenBone closes a EUR10m Series B round | GreenBone Ortho SpA, a specialist in the field of bone regeneration, has completed a EUR10 million S... |
| 31.03.2021 | OncoResponse Raises $40.6 Million Series C Financing | – New capital will fund lead antibody, OR2805, through Phase 1 and 2 clinical studies |
| 24.03.2021 | - | Grand Duchy of Luxembourg – 3B FUTURE HEALTH GP S.a.r.l. is pleased to announce the launch of the 3B... |
| 18.03.2021 | Gain Therapeutics Announces Pricing of Initial Public Offeri... | BETHESDA, Md., March 18, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (“Gainâ€) today announce... |
| 09.03.2021 | NeoPhore Announces £15.2m Financing to Advance DNA Mismatch ... | Round led by Claris Ventures with 2Invest, 3B Future Health Fund and Astellas Venture Management |
| 24.02.2021 | NovellusDx Establishes Fore Biotherapeutics U.S. as its Oper... | Company launch and rebrand in the US reflects expert leadership in precision oncology and a new busi... |
| 04.02.2021 | - | BETHESDA, Md., Feb. 04, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc., (“Gainâ€) a biotechnolog... |
| 21.09.2020 | Novellus Closes $57M Series C Financing | JERUSALEM–(BUSINESS WIRE)–Novellus, Ltd., a clinical-stage biotechnology company focused on precisio... |
| 10.09.2020 | - | BETHESDA, Md., Sept. 10, 2020 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc., (“Gainâ€) a biotechnolo... |
| 21.07.2020 | Gain Therapeutics, Inc. Announces Close of $10 Million Serie... | Eric I Richman appointed CEO and Director |
| 14.07.2020 | 3B Future Health Fund Announces New Investment in iOnctura | MONACO, PRINCIPALITY OF MONACO, 14 July 2020: 3B Future Health Fund, previously known as Helsinn Inv... |
| 08.06.2020 | QuantuMDx attains CE-IVD marking for SARS-CoV-2 Test | QuantuMDx Group today announces its SARS-CoV-2 detection assay has been CE-IVD marked under the In... |
| 14.04.2020 | OncoResponse Appoints Robert Lechleider, MD as Chief Medical... | SEATTLE, WA / ACCESSWIRE / April 14, 2020 / OncoResponse, a biotechnology company
developing human a... |
| 31.01.2020 | Lyfebulb and Helsinn Announce the Winners of the Third Annua... | MONACO, PRINCIPALITY OF MONACO, AND NEW YORK, NY, USA, January 31, 2020: Lyfebulb, a patient empower... |
| 30.01.2020 | The GreenBone bone substitute achieves CE certification | GreenBone received CE mark approval for the GreenBone Bone SubstituteTM |
| 15.07.2019 | Helsinn Investment Fund Announces First Exit | Luxembourg, 15 July 2019 Helsinn Investment Fund S.A, SICAR, a fund focused on early-stage investmen... |
| 19.03.2019 | Winners of the Second Annual Lyfebulb-Helsinn Innovation Sum... | MONACO, PRINCIPALITY OF MONACO and NEW YORK, NY, MARCH 19, 2019: |
| 19.02.2019 | Helsinn Investment Fund Invests €1 Million in Gain Therape... | Luxembourg, 19 February 2019: Helsinn Investment Fund S.A, SICAR, a fund focused on early-stage inve... |
| 23.01.2019 | QuantuMDx & St George’s begin field study: cervical ca... | To coincide with Cervical Cancer Prevention Week, QuantuMDx Group has announced the start of a field... |
| 30.04.2018 | NovellusDx Announces It Has Completed an Equity Financing of... | Jerusalem, Israel, 30 April 2018 – NovellusDx, the leader in functional genomics, today announced ... |
| 28.03.2018 | Winners of the Inaugural Lyfebulb-Helsinn Innovation Summit ... | Lorenzo Pradella of GreenBone Ortho, srl has been selected from eleven finalists as the winner of th... |
| 14.03.2018 | On Target Laboratories Raises Additional Capital from H.I.G.... | WEST LAFAYETTE, Ind. 14 March 2018 – On Target Laboratories, Inc., a privately-held biotechnology ... |
| 30.01.2018 | Helsinn and the Scientific Centre of Monaco Sign Collaborati... | Lugano, Switzerland, 30 January 2018 – Helsinn International Services, Sarl, a Monaco-based affili... |
| 05.09.2017 | AMAL Therapeutics Raises €8 Million (CHF 8.8 Million) in F... | Financing round co-led by Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment F... |
| 16.06.2017 | Helsinn Investment Fund Leads the Financial Round in GreenBo... | Lugano, Switzerland, 16 June 2017: Helsinn Investment Fund S.A., a fund focused on early-stage inves... |
| 08.05.2017 | Helsinn Investment Fund Invests in Aadi Bioscience | Luxembourg, 8 May 2017: Helsinn Investment Fund S.A, a fund focused on early-stage investment opport... |
| 10.10.2016 | Helsinn Group Introduces Helsinn Investment Fund | Lugano, Switzerland, 10 October 2016: Helsinn, the Swiss Pharmaceutical Group focused on building qu... |
| 10.10.2016 | Helsinn Investment Fund to Invest $3.5 Million in OncoRespon... | Lugano, Switzerland, 10 October 2016: Helsinn Investment Fund S.A, a fund focused on early-stage inv... |
| 10.10.2016 | Helsinn Investment Fund Invests £2.0 Million in QuantuMDx | Lugano, Switzerland, 10 October 2016: Helsinn Investment Fund S.A., a fund focused on early-stage in... |
| 08.08.2016 | Helsinn Group and MEI Pharma Enter Strategic Agreement for t... | MEI Pharma to receive $20 million in near-term cash payments, plus up to $444 million in potential m... |
